People: Alexion Pharmaceuticals Inc (ALXN.O)
Dr. Leonard Bell, M.D., is Chairman of the Board of Alexion Pharmaceuticals, Inc., since April 1, 2015. He is no longer Chief Executive Officer of Alexion Pharmaceuticals, Inc. From 1991 to 1992, Dr. Bell is the principal founder of Alexion and has been a director of Alexion since February 1992 and the Company’s Chief Executive Officer since January 1992. From 1991 to 1992, Dr. Bell was an Assistant Professor of Medicine and Pathology and co-Director of the program in Vascular Biology at the Yale University School of Medicine. From 1990 to 1992, Dr. Bell was an attending physician at the Yale-New Haven Hospital and an Assistant Professor in the Department of Internal Medicine at the Yale University School of Medicine. Dr. Bell was a recipient of the Physician Scientist Award from the National Institutes of Health and Grant-in-Aid from the American Heart Association as well as various honors and awards from academic and professional organizations. His work has resulted in more than 20 scientific publications and 9 patent applications. Dr. Bell received his A.B. from Brown University and M.D. from Yale University School of Medicine. Dr. Bell is currently an Adjunct Assistant Professor of Medicine and Pathology at the Yale University School of Medicine.
|Total Annual Compensation, USD||1,280,000|
|Restricted Stock Awards, USD||8,165,580|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||11,125,100|
|Fiscal Year Total, USD||20,570,700|